共 50 条
- [31] Efficacy and safety of cadonilimab, an anti-PD-1/CTLA4 bi-specific antibody, in previously treated recurrent or metastatic (R/M) cervical cancer: a multicenter, open-label, single-arm, phase II trialGYNECOLOGIC ONCOLOGY, 2022, 166 : S47 - S48Wu, Xiaohua论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R ChinaJi, Jiafu论文数: 0 引用数: 0 h-index: 0机构: Beijing Canc Hosp, Beijing, Peoples R China Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R ChinaLou, Hanmei论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Canc Hosp, Hangzhou, Peoples R China Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R ChinaLi, Yunxia论文数: 0 引用数: 0 h-index: 0机构: Ningxia Med Univ, Gen Hosp, Yinchuan, Ningxia, Peoples R China Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R ChinaFeng, Mei论文数: 0 引用数: 0 h-index: 0机构: Fujian Prov Canc Hosp, Fuzhou, Peoples R China Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R ChinaXu, Nong论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Affiliated Hosp 1, Coll Med, Hangzhou, Peoples R China Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R ChinaLi, Yuzhi论文数: 0 引用数: 0 h-index: 0机构: Bengbu Med Coll, Affiliated Hosp 1, Bengbu, Anhui, Peoples R China Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R ChinaWang, Jing论文数: 0 引用数: 0 h-index: 0机构: Hunan Canc Hosp, Changsha, Hunan, Peoples R China Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R ChinaHuang, Yi论文数: 0 引用数: 0 h-index: 0机构: Hubei Canc Hosp, Wuhan, Peoples R China Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R ChinaLou, Ge论文数: 0 引用数: 0 h-index: 0机构: Harbin Med Univ, Canc Hosp, Harbin, Peoples R China Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R ChinaAn, Ruifang论文数: 0 引用数: 0 h-index: 0机构: Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Peoples R China Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R ChinaLi, Changzheng论文数: 0 引用数: 0 h-index: 0机构: Shandong Canc Hosp, Jinan, Peoples R China Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R ChinaZhou, Qi论文数: 0 引用数: 0 h-index: 0机构: Chongqing Univ, Canc Hosp, Chongqing, Peoples R China Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R ChinaHuang, Xin论文数: 0 引用数: 0 h-index: 0机构: Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R ChinaZhao, Enfeng论文数: 0 引用数: 0 h-index: 0机构: Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R ChinaLiu, Tianshu论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R ChinaFan, Qingxia论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R ChinaLi, Guiling论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Techno, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R ChinaLi, Baiyong论文数: 0 引用数: 0 h-index: 0机构: Akeso Biopharma Inc, Zhongshan, Peoples R China Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R ChinaXia, Yu论文数: 0 引用数: 0 h-index: 0机构: Akeso Biopharma Inc, Zhongshan, Peoples R China Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
- [32] A Phase II trial of docetaxel and cisplatin in patients with recurrent or metastatic nasopharyngeal carcinomaORAL ONCOLOGY, 2002, 38 (07) : 686 - 690McCarthy, JS论文数: 0 引用数: 0 h-index: 0机构: Univ Hlth Network, Princess Margaret Hosp, Dept Med Oncol & Hematol, Toronto, ON M5G 2M9, CanadaTannock, IF论文数: 0 引用数: 0 h-index: 0机构: Univ Hlth Network, Princess Margaret Hosp, Dept Med Oncol & Hematol, Toronto, ON M5G 2M9, CanadaDegendorfer, P论文数: 0 引用数: 0 h-index: 0机构: Univ Hlth Network, Princess Margaret Hosp, Dept Med Oncol & Hematol, Toronto, ON M5G 2M9, CanadaPanzarella, T论文数: 0 引用数: 0 h-index: 0机构: Univ Hlth Network, Princess Margaret Hosp, Dept Med Oncol & Hematol, Toronto, ON M5G 2M9, CanadaFurlan, M论文数: 0 引用数: 0 h-index: 0机构: Univ Hlth Network, Princess Margaret Hosp, Dept Med Oncol & Hematol, Toronto, ON M5G 2M9, CanadaSiu, LL论文数: 0 引用数: 0 h-index: 0机构: Univ Hlth Network, Princess Margaret Hosp, Dept Med Oncol & Hematol, Toronto, ON M5G 2M9, Canada
- [33] Phase II trial of everolimus in patients with previously treated recurrent or metastatic head and neck squamous cell carcinomaHEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 (12): : 1759 - 1764Geiger, Jessica L.论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Div Hematol Oncol, Dept Internal Med, Pittsburgh, PA USA Univ Pittsburgh, Div Hematol Oncol, Dept Internal Med, Pittsburgh, PA USABauman, Julie E.论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Div Hematol Oncol, Dept Internal Med, Pittsburgh, PA USA Univ Pittsburgh, Div Hematol Oncol, Dept Internal Med, Pittsburgh, PA USAGibson, Michael K.论文数: 0 引用数: 0 h-index: 0机构: Case Western Univ, Div Hematol Oncol, Dept Internal Med, Cleveland, OH USA Univ Pittsburgh, Div Hematol Oncol, Dept Internal Med, Pittsburgh, PA USAGooding, William E.论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Inst Canc, Biostat Facil, Pittsburgh, PA USA Univ Pittsburgh, Div Hematol Oncol, Dept Internal Med, Pittsburgh, PA USAVaradarajan, Prakash论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Hematol Oncol, San Antonio, TX 78229 USA Univ Pittsburgh, Div Hematol Oncol, Dept Internal Med, Pittsburgh, PA USAKotsakis, Athanasios论文数: 0 引用数: 0 h-index: 0机构: Univ Crete, Sch Med, Iraklion, Greece Univ Pittsburgh, Div Hematol Oncol, Dept Internal Med, Pittsburgh, PA USAMartin, Daniel论文数: 0 引用数: 0 h-index: 0机构: Natl Inst Dent & Craniofacial Res, Bethesda, MD USA Univ Pittsburgh, Div Hematol Oncol, Dept Internal Med, Pittsburgh, PA USAGutkind, Jorge Silvio论文数: 0 引用数: 0 h-index: 0机构: Natl Inst Dent & Craniofacial Res, Bethesda, MD USA Univ Pittsburgh, Div Hematol Oncol, Dept Internal Med, Pittsburgh, PA USAHedberg, Matthew L.论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA Univ Pittsburgh, Div Hematol Oncol, Dept Internal Med, Pittsburgh, PA USAGrandis, Jennifer R.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, Dept Otolaryngol, San Francisco, CA 94143 USA Univ Pittsburgh, Div Hematol Oncol, Dept Internal Med, Pittsburgh, PA USA论文数: 引用数: h-index:机构:
- [34] Phase II multicenter study to evaluate the efficacy and safety of Tarceva™ (erlotinib, OSI-774) in women with previously treated locally advanced or metastatic breast cancer.BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S115 - S115Winer, E论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USACobleigh, M论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USADickler, M论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USAMiller, K论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USAFehrenbacher, L论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USAJones, C论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USAJustice, R论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USA
- [35] Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II studyJOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10 : 1 - 8Xu, Rui-Hua论文数: 0 引用数: 0 h-index: 0机构: Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Dept Med Oncol, Guangzhou 510060, Guangdong, Peoples R China Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Dept Med Oncol, Guangzhou 510060, Guangdong, Peoples R ChinaLi, Jin论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Dept Med Oncol, Shanghai Med Coll, Shanghai Canc Ctr, Shanghai 200032, Peoples R China Tongji Univ, Shanghai East Hosp, Dept Oncol, 150 Jimo Rd, Shanghai 200120, Peoples R China Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Dept Med Oncol, Guangzhou 510060, Guangdong, Peoples R ChinaBai, Yuxian论文数: 0 引用数: 0 h-index: 0机构: Harbin Med Univ, Dept Med Oncol, Canc Hosp, Harbin 150081, Peoples R China Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Dept Med Oncol, Guangzhou 510060, Guangdong, Peoples R ChinaXu, Jianming论文数: 0 引用数: 0 h-index: 0机构: Acad Mil Med Sci, Hosp PLA 307, Dept Med Oncol, Beijing 100071, Peoples R China Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Dept Med Oncol, Guangzhou 510060, Guangdong, Peoples R ChinaLiu, Tianshu论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Shanghai Med Coll, Dept Med Oncol, Zhongshan Hosp, Shanghai 200032, Peoples R China Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Dept Med Oncol, Guangzhou 510060, Guangdong, Peoples R ChinaShen, Lin论文数: 0 引用数: 0 h-index: 0机构: Beijing Canc Hosp, Dept Med Oncol, Beijing 100142, Peoples R China Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Dept Med Oncol, Guangzhou 510060, Guangdong, Peoples R ChinaWang, Liwei论文数: 0 引用数: 0 h-index: 0机构: Shanghai First Peoples Hosp, Dept Med Oncol, Shanghai 200090, Peoples R China Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Dept Med Oncol, Guangzhou 510060, Guangdong, Peoples R ChinaPan, Hongming论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Med Oncol, Hangzhou 310016, Zhejiang, Peoples R China Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Dept Med Oncol, Guangzhou 510060, Guangdong, Peoples R ChinaCao, Junning论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Dept Med Oncol, Shanghai Med Coll, Shanghai Canc Ctr, Shanghai 200032, Peoples R China Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Dept Med Oncol, Guangzhou 510060, Guangdong, Peoples R ChinaZhang, Dongsheng论文数: 0 引用数: 0 h-index: 0机构: Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Dept Med Oncol, Guangzhou 510060, Guangdong, Peoples R China Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Dept Med Oncol, Guangzhou 510060, Guangdong, Peoples R ChinaFan, Songhua论文数: 0 引用数: 0 h-index: 0机构: Hutchison MediPharma Ltd, Shanghai 201203, Peoples R China Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Dept Med Oncol, Guangzhou 510060, Guangdong, Peoples R ChinaHua, Ye论文数: 0 引用数: 0 h-index: 0机构: Hutchison MediPharma Ltd, Shanghai 201203, Peoples R China Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Dept Med Oncol, Guangzhou 510060, Guangdong, Peoples R ChinaSu, Weiguo论文数: 0 引用数: 0 h-index: 0机构: Hutchison MediPharma Ltd, Shanghai 201203, Peoples R China Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Dept Med Oncol, Guangzhou 510060, Guangdong, Peoples R China
- [36] Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II studyJournal of Hematology & Oncology, 10Rui-Hua Xu论文数: 0 引用数: 0 h-index: 0机构: Collaborative Innovation Center for Cancer Medicine,Department of Medical Oncology, Sun YatJin Li论文数: 0 引用数: 0 h-index: 0机构: Collaborative Innovation Center for Cancer Medicine,Department of Medical Oncology, Sun YatYuxian Bai论文数: 0 引用数: 0 h-index: 0机构: Collaborative Innovation Center for Cancer Medicine,Department of Medical Oncology, Sun YatJianming Xu论文数: 0 引用数: 0 h-index: 0机构: Collaborative Innovation Center for Cancer Medicine,Department of Medical Oncology, Sun YatTianshu Liu论文数: 0 引用数: 0 h-index: 0机构: Collaborative Innovation Center for Cancer Medicine,Department of Medical Oncology, Sun YatLin Shen论文数: 0 引用数: 0 h-index: 0机构: Collaborative Innovation Center for Cancer Medicine,Department of Medical Oncology, Sun YatLiwei Wang论文数: 0 引用数: 0 h-index: 0机构: Collaborative Innovation Center for Cancer Medicine,Department of Medical Oncology, Sun YatHongming Pan论文数: 0 引用数: 0 h-index: 0机构: Collaborative Innovation Center for Cancer Medicine,Department of Medical Oncology, Sun YatJunning Cao论文数: 0 引用数: 0 h-index: 0机构: Collaborative Innovation Center for Cancer Medicine,Department of Medical Oncology, Sun YatDongsheng Zhang论文数: 0 引用数: 0 h-index: 0机构: Collaborative Innovation Center for Cancer Medicine,Department of Medical Oncology, Sun YatSonghua Fan论文数: 0 引用数: 0 h-index: 0机构: Collaborative Innovation Center for Cancer Medicine,Department of Medical Oncology, Sun YatYe Hua论文数: 0 引用数: 0 h-index: 0机构: Collaborative Innovation Center for Cancer Medicine,Department of Medical Oncology, Sun YatWeiguo Su论文数: 0 引用数: 0 h-index: 0机构: Collaborative Innovation Center for Cancer Medicine,Department of Medical Oncology, Sun Yat
- [37] A Multicenter phase II study of bortezomib in recurrent or metastatic sarcomasCANCER, 2005, 103 (07) : 1431 - 1438Maki, RG论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USAKraft, AS论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USAScheu, K论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USAYamada, J论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USAWadler, S论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USAAntonescu, CR论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USAWright, JJ论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USASchwartz, GK论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
- [38] Efficacy, safety and biomarkers of SG001 for patients with previously treated recurrent or metastatic cervical cancer: an open-label, multicenter, phase Ib trialCANCER COMMUNICATIONS, 2024, 44 (09) : 1042 - 1046Zuo, Jing论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Dept Gynecol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Pan Jia Yuan South Lane, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Gynecol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Pan Jia Yuan South Lane, Beijing 100021, Peoples R ChinaDuan, Wei论文数: 0 引用数: 0 h-index: 0机构: Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Gynecol Oncol, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Gynecol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Pan Jia Yuan South Lane, Beijing 100021, Peoples R ChinaZhao, Mingxuan论文数: 0 引用数: 0 h-index: 0机构: Third Peoples Hosp Kunming, Yunnan Clin Ctr Infect Dis, Dept Hepatol 1, Kunming, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Gynecol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Pan Jia Yuan South Lane, Beijing 100021, Peoples R ChinaChen, Zhendong论文数: 0 引用数: 0 h-index: 0机构: Second Affiliated Hosp Anhui Med Univ, Dept Oncol, Hefei, Anhui, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Gynecol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Pan Jia Yuan South Lane, Beijing 100021, Peoples R ChinaLin, Jie论文数: 0 引用数: 0 h-index: 0机构: Second Affiliated Hosp Kunming Med Univ, Dept Dermatol & Venereol, Kunming, Yunnan, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Gynecol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Pan Jia Yuan South Lane, Beijing 100021, Peoples R ChinaShi, Huaqiu论文数: 0 引用数: 0 h-index: 0机构: First Affiliated Hosp Gannan Med Univ, Dept Oncol, Ganzhou, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Gynecol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Pan Jia Yuan South Lane, Beijing 100021, Peoples R ChinaJiang, Ou论文数: 0 引用数: 0 h-index: 0机构: Second Peoples Hosp Neijiang, Dept Pathol, Neijiang, Sichuan, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Gynecol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Pan Jia Yuan South Lane, Beijing 100021, Peoples R ChinaZhang, Youzhong论文数: 0 引用数: 0 h-index: 0机构: Qilu Hosp Shandong Univ, Dept Gynecol, Jinan, Shandong, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Gynecol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Pan Jia Yuan South Lane, Beijing 100021, Peoples R ChinaFang, Meiyu论文数: 0 引用数: 0 h-index: 0机构: Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Dept Rare & Head & Neck Oncol, Hangzhou, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Gynecol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Pan Jia Yuan South Lane, Beijing 100021, Peoples R ChinaWang, Li论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Canc Hosp, Henan Canc Hosp, Dept Immunotherapy, Zhengzhou, Henan, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Gynecol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Pan Jia Yuan South Lane, Beijing 100021, Peoples R ChinaWang, Wei论文数: 0 引用数: 0 h-index: 0机构: Hunan Canc Hosp, Dept Gynaecol, Changsha, Hunan, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Gynecol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Pan Jia Yuan South Lane, Beijing 100021, Peoples R ChinaHuang, Yong论文数: 0 引用数: 0 h-index: 0机构: Second Peoples Hosp Hefei, Dept Oncol, Hefei, Anhui, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Gynecol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Pan Jia Yuan South Lane, Beijing 100021, Peoples R ChinaYu, Junyan论文数: 0 引用数: 0 h-index: 0机构: Changzhi Med Coll, Affiliated Heping Hosp, Dept Galactophore, Changzhi, Shanxi, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Gynecol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Pan Jia Yuan South Lane, Beijing 100021, Peoples R ChinaZhang, Xiaoxue论文数: 0 引用数: 0 h-index: 0机构: CSPC Pharmaceut Grp Co Ltd, Shijiazhuang, Hebei, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Gynecol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Pan Jia Yuan South Lane, Beijing 100021, Peoples R ChinaPu, Weiqing论文数: 0 引用数: 0 h-index: 0机构: CSPC Pharmaceut Grp Co Ltd, Shijiazhuang, Hebei, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Gynecol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Pan Jia Yuan South Lane, Beijing 100021, Peoples R ChinaHao, Deshun论文数: 0 引用数: 0 h-index: 0机构: CSPC Pharmaceut Grp Co Ltd, Shijiazhuang, Hebei, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Gynecol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Pan Jia Yuan South Lane, Beijing 100021, Peoples R ChinaShe, Fenglin论文数: 0 引用数: 0 h-index: 0机构: CSPC Pharmaceut Grp Co Ltd, Shijiazhuang, Hebei, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Gynecol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Pan Jia Yuan South Lane, Beijing 100021, Peoples R ChinaYang, Xiugao论文数: 0 引用数: 0 h-index: 0机构: CSPC Pharmaceut Grp Co Ltd, Shijiazhuang, Hebei, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Gynecol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Pan Jia Yuan South Lane, Beijing 100021, Peoples R ChinaChen, Ying论文数: 0 引用数: 0 h-index: 0机构: CSPC Pharmaceut Grp Co Ltd, Shijiazhuang, Hebei, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Gynecol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Pan Jia Yuan South Lane, Beijing 100021, Peoples R ChinaTang, Qizhi论文数: 0 引用数: 0 h-index: 0机构: CSPC Pharmaceut Grp Co Ltd, Shijiazhuang, Hebei, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Gynecol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Pan Jia Yuan South Lane, Beijing 100021, Peoples R ChinaZhang, Xiao论文数: 0 引用数: 0 h-index: 0机构: CSPC Pharmaceut Grp Co Ltd, Shijiazhuang, Hebei, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Gynecol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Pan Jia Yuan South Lane, Beijing 100021, Peoples R ChinaNiu, Miao论文数: 0 引用数: 0 h-index: 0机构: CSPC Pharmaceut Grp Co Ltd, Shijiazhuang, Hebei, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Gynecol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Pan Jia Yuan South Lane, Beijing 100021, Peoples R ChinaSong, Yan'e论文数: 0 引用数: 0 h-index: 0机构: CSPC Pharmaceut Grp Co Ltd, Shijiazhuang, Hebei, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Gynecol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Pan Jia Yuan South Lane, Beijing 100021, Peoples R ChinaWu, Lingying论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Dept Gynecol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Pan Jia Yuan South Lane, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Gynecol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Pan Jia Yuan South Lane, Beijing 100021, Peoples R China
- [39] A phase II study of patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein–Barr virus DNA as a biomarker of efficacyCancer Chemotherapy and Pharmacology, 2008, 62 : 59 - 64Brigette Ma论文数: 0 引用数: 0 h-index: 0机构: Prince of Wales Hospital,Department of Clinical Oncology and Sir Y.K. Pao Cancer CenterEdwin P. Hui论文数: 0 引用数: 0 h-index: 0机构: Prince of Wales Hospital,Department of Clinical Oncology and Sir Y.K. Pao Cancer CenterAnn King论文数: 0 引用数: 0 h-index: 0机构: Prince of Wales Hospital,Department of Clinical Oncology and Sir Y.K. Pao Cancer CenterK. F. To论文数: 0 引用数: 0 h-index: 0机构: Prince of Wales Hospital,Department of Clinical Oncology and Sir Y.K. Pao Cancer CenterFrankie Mo论文数: 0 引用数: 0 h-index: 0机构: Prince of Wales Hospital,Department of Clinical Oncology and Sir Y.K. Pao Cancer CenterSing F. Leung论文数: 0 引用数: 0 h-index: 0机构: Prince of Wales Hospital,Department of Clinical Oncology and Sir Y.K. Pao Cancer CenterMichael Kam论文数: 0 引用数: 0 h-index: 0机构: Prince of Wales Hospital,Department of Clinical Oncology and Sir Y.K. Pao Cancer CenterY. M. Dennis Lo论文数: 0 引用数: 0 h-index: 0机构: Prince of Wales Hospital,Department of Clinical Oncology and Sir Y.K. Pao Cancer CenterBenny Zee论文数: 0 引用数: 0 h-index: 0机构: Prince of Wales Hospital,Department of Clinical Oncology and Sir Y.K. Pao Cancer CenterTony Mok论文数: 0 引用数: 0 h-index: 0机构: Prince of Wales Hospital,Department of Clinical Oncology and Sir Y.K. Pao Cancer CenterAnil Ahuja论文数: 0 引用数: 0 h-index: 0机构: Prince of Wales Hospital,Department of Clinical Oncology and Sir Y.K. Pao Cancer CenterAnthony T. C. Chan论文数: 0 引用数: 0 h-index: 0机构: Prince of Wales Hospital,Department of Clinical Oncology and Sir Y.K. Pao Cancer Center
- [40] A phase II study of pemetrexed combined with cisplatin in patients (pts) with recurrent or metastatic nasopharyngeal carcinoma.JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)Lee, A. W. M.论文数: 0 引用数: 0 h-index: 0机构: Pamela Youde Nethersole Eastern Hosp, Hong Kong, Hong Kong, Peoples R ChinaYau, T. K.论文数: 0 引用数: 0 h-index: 0机构: Pamela Youde Nethersole Eastern Hosp, Hong Kong, Hong Kong, Peoples R ChinaShum, T. C.论文数: 0 引用数: 0 h-index: 0机构: Pamela Youde Nethersole Eastern Hosp, Hong Kong, Hong Kong, Peoples R ChinaNg, W. T.论文数: 0 引用数: 0 h-index: 0机构: Pamela Youde Nethersole Eastern Hosp, Hong Kong, Hong Kong, Peoples R ChinaChan, L. L.论文数: 0 引用数: 0 h-index: 0机构: Pamela Youde Nethersole Eastern Hosp, Hong Kong, Hong Kong, Peoples R ChinaYeung, R. M.论文数: 0 引用数: 0 h-index: 0机构: Pamela Youde Nethersole Eastern Hosp, Hong Kong, Hong Kong, Peoples R China